We are pleased to announce that Pharmatest Services will participate in the AACR Annual Meeting 2026, taking place in San Diego on April 17–22.

We look forward to meeting our partners and researchers from the global oncology community and to discussing our findings in multiple myeloma research:

• In vitro and in vivo evaluation of bortezomib using the 5TGM1 cell line and a syngeneic mouse model of multiple myeloma
• Preclinical efficacy of a bispecific NK cell engager studied using a humanized multiple myeloma mouse model

The latter research was carried out within the Eurostars‑funded NK ENGAGE project, in collaboration with leading academic institutions, Pharmatest Services, and Oncopeptides.

Read more:

• Preclinical data on novel NK-Cell engager to be presented at the AACR Annual Meeting 2026 – Oncopeptides
• Meet the Pharmatest team at the AACR

Visit us at booth #5044 to exchange insights on preclinical strategies in cancer research, including bone metastases — and if you are unable to attend in person, our posters will be accessible after the meeting. Reach out if interested and stay tuned!